Newron Pharmaceuticals S.p.A. | WebDisclosure

Basculer en Français

11195	Companies
247703	Keywords
175502	Articles
133858	Press releases

Headlines Articles Press releases Newron Pharmaceuticals S.p.A.

Home
Companies
Newron Pharmaceuticals S.p.A.

BRIEF

published on 09/02/2026 at 07:05, 1 month 17 days ago

Newron Completes Screening for Pivotal Phase 3 ENIGMA-TRS 1 Study with Evenamide

Phase 3 Trial Newron Pharmaceuticals Evenamide Treatment-resistant Schizophrenia ENIGMA-TRS 1 Study
PRESS RELEASE

published on 09/02/2026 at 07:00, 1 month 17 days ago

Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
Newron Pharmaceuticals completes screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study on evenamide for treatment-resistant schizophrenia patients

Schizophrenia Newron Pharmaceuticals Evenamide Phase 3 ENIGMA-TRS 1
BRIEF

published on 04/23/2026 at 15:15, 5 months 25 days ago

Newron Pharmaceuticals annonce les résultats de son assemblée générale annuelle 2026

Newron Pharmaceuticals Evenamide Membres Du Conseil D'administration Assemblée Générale Annuelle 2026 Xadago®
BRIEF

published on 04/23/2026 at 15:15, 5 months 25 days ago

Newron Pharmaceuticals Announces AGM 2026 Results

Board Members Newron Pharmaceuticals Evenamide AGM 2026 Xadago®
PRESS RELEASE

published on 04/23/2026 at 15:10, 5 months 25 days ago

Newron announces AGM 2026 results
Newron Pharmaceuticals S.p.A. announces successful AGM 2026 results including new Board members. Focus on developing therapies for nervous system diseases

Board Members Newron Pharmaceuticals Thérapies AGM 2026 Nervous System Diseases
BRIEF

published on 03/24/2026 at 07:05, 6 months 26 days ago

Newron annonce ses résultats pour 2025 et ses perspectives pour 2026.

Résultats Financiers Traitement De La Schizophrénie Perspectives Pour 2026 Brevet Accordé Essais Sur L'Evenamide
BRIEF

published on 03/24/2026 at 07:05, 6 months 26 days ago

Newron Announces 2025 Results and 2026 Outlook

Financial Results Schizophrenia Treatment Patent Grant 2026 Outlook Evenamide Trials
PRESS RELEASE

published on 03/24/2026 at 07:00, 6 months 26 days ago

Newron presents 2025 financial results and provides 2026 outlook
Newron Pharmaceuticals S.p.A. presents 2025 financial results and 2026 outlook, including progress on evenamide clinical trials and IP expansion

Financial Results Clinical Trials Newron Pharmaceuticals 2026 Outlook IP Expansion
BRIEF

published on 03/20/2026 at 07:05, 6 months 30 days ago

Newron Pharmaceuticals to Present at SIRS 2026

Newron Pharmaceuticals Evenamide Treatment-resistant Schizophrenia Glutamate Modulation Schizophrenia Research
BRIEF

published on 03/20/2026 at 07:05, 6 months 30 days ago

Newron Pharmaceuticals présentera ses travaux au SIRS 2026

Newron Pharmaceuticals Evenamide Schizophrénie Résistante Au Traitement Modulation Du Glutamate Recherche Sur La Schizophrénie

Accesswire

Published on 10/19/2026 at 09:05, 2 hours 30 minutes ago

BioNxt Completes GMP Manufacturing and Submits Clinical Trial Application for Sublingual Cladribine Drug Candidate
Published on 10/17/2026 at 03:20, 2 days 8 hours ago

Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 2 days 8 hours ago

Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 2 days 12 hours ago

Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 2 days 12 hours ago

NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials

View all ACCESSWIRE

EQS Group

Published on 10/19/2026 at 11:28, 7 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 10/19/2026 at 11:24, 11 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 10/19/2026 at 11:16, 19 minutes ago

On the way to a European lunar infrastructure: ESA awards OHB OASIS studies
Published on 10/19/2026 at 11:12, 23 minutes ago

EQS-Adhoc: Katjes Greenfood sets volume of new 2026/2031 corporate bond at EUR 44 million
Published on 10/19/2026 at 11:10, 25 minutes ago

Confederation of African Football (CAF)

Les Echos

Published on 10/19/2026 at 10:49, 45 minutes ago

261019 BENETEAU Transactions sur actions propres
Published on 10/19/2026 at 08:15, 3 hours 20 minutes ago

Carrefour strengthens its leadership in convenience retail in France with the acquisition of Codifrance
Published on 10/19/2026 at 08:15, 3 hours 20 minutes ago

Carrefour renforce son leadership dans le commerce de proximité en France avec l’acquisition de Codifrance
Published on 10/16/2026 at 19:54, 2 days 15 hours ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 septembre 2026
Published on 10/16/2026 at 18:48, 2 days 16 hours ago

Disclosure of transactions in own shares from October 12 to October 16, 2026

View all LES ECHOS COMFI WIRE